## Gene Summary
NOS3 (Nitric Oxide Synthase 3), also known as endothelial nitric oxide synthase (eNOS), is primarily expressed in endothelial cells. This enzyme is responsible for the production of nitric oxide (NO), a key molecular mediator involved in vascular smooth muscle relaxation and vasodilation, thereby playing a crucial role in regulating blood pressure and overall cardiovascular function. NOS3 is activated in a calcium/calmodulin-dependent manner and is involved in various biological responses including modulation of vascular tone, insulin secretion, and neural development.

## Gene Drugs, Diseases, Phenotypes, and Pathways
The primary pathway associated with NOS3 involves nitric oxide biosynthesis. Nitric oxide acts as a vasodilator and an inhibitory neurotransmitter and plays an instrumental role in cardiovascular homeostasis and disease. Variations and dysfunctions in NOS3 are linked to several cardiovascular diseases, such as hypertension, coronary artery disease, and myocardial infarction. The gene's functioning impacts endothelial function and is crucial in modulating responses to ischemic injury and atherogenesis. Additionally, polymorphisms in NOS3 have been associated with increased susceptibility to various complications including diabetic nephropathy and erectile dysfunction.

## Pharmacogenetics
Polymorphisms in NOS3 influence the pharmacological response to several cardiovascular agents. The gene's variants are particularly relevant in the context of drugs like statins and antihypertensive medications. Patients carrying certain NOS3 polymorphisms may show different responses to these treatments, relating to variations in drug efficacy and risk of side effects. For instance, the T-786C variant has been shown to influence the response to nitroglycerin and other nitrate-based vasodilators, which act partly through the NO pathway. In personalized medicine, understanding a patient's NOS3 genotype can be essential in optimizing therapeutic strategies to improve vascular function and reduce cardiovascular risk.